Skip to main content
Erschienen in: Quality of Life Research 7/2017

25.02.2017

Patient-reported symptoms of radiation dermatitis during breast cancer radiotherapy: a pilot study

verfasst von: Jieun Lee, Won Park, Doo Ho Choi, Seung Jae Huh, Im-Ryung Kim, Danbee Kang, Juhee Cho

Erschienen in: Quality of Life Research | Ausgabe 7/2017

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Purpose

To find out which symptoms most frequently and severely affect breast cancer patients during radiotherapy and how patients manage the symptoms and unmet needs.

Methods

A cross-sectional survey was conducted with 111 patients who receive radiotherapy for breast cancer from January to April 2015 at Samsung Medical Center in Seoul, South Korea. Participants were asked about symptoms and discomfort due to radiotherapy, management methods for radiation dermatitis, unmet needs for radiation dermatitis care, and clinical and socio-demographic information.

Results

Of total, 108 out of 111 patients (97.3%) reported symptoms related to radiation dermatitis. Hyperpigmentation was the most commonly reported uncomfortable symptom followed by erythema. On average, patients reported 8.6 radiotherapy-induced skin problems (range, 0–11). Of total, 59 (53.2%) patients stated that they wanted care for radiation dermatitis, and 80.0, 59.4, and 51% of patients searched for information, used products, and visited the hospital to manage radiotherapy-related skin problems. Patients who experienced dryness, burning feelings, irritation, roughness, and hyperpigmentation were 11.73, 7.02, 5.10, 4.27, and 2.80 times more likely to have management needs than patients without those symptoms, respectively, adjusting age, current cycle of radiation therapy, chemotherapy, and type of surgery.

Conclusions

Most of the breast cancer patients experience multiple symptoms associated with radiation dermatitis. Hyperpigmentation was the most common and uncomfortable symptom followed by erythema. Majority of patients wanted management for radiation dermatitis and patients who experienced dryness, burning feelings, irritation, roughness, and hyperpigmentation had higher needs for radiation dermatitis management.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literatur
1.
Zurück zum Zitat Waghmare, C. M. (2013). Radiation burn–from mechanism to management. Burns, 39(2), 212–219.CrossRefPubMed Waghmare, C. M. (2013). Radiation burn–from mechanism to management. Burns, 39(2), 212–219.CrossRefPubMed
2.
Zurück zum Zitat Ha, B., Suh, H. S., Lee, J., Lee, K. J., Lee, R., & Moon, B. I. (2013). Long-term results of forward intensity-modulated radiation therapy for patients with early-stage breast cancer. Radiation Oncology Journal, 31(4), 191–198.CrossRefPubMedPubMedCentral Ha, B., Suh, H. S., Lee, J., Lee, K. J., Lee, R., & Moon, B. I. (2013). Long-term results of forward intensity-modulated radiation therapy for patients with early-stage breast cancer. Radiation Oncology Journal, 31(4), 191–198.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Hymes, S. R., Strom, E. A., & Fife, C. (2006). Radiation dermatitis: Clinical presentation, pathophysiology, and treatment 2006. Journal of the American Academy of Dermatology, 54(1), 28–46.CrossRefPubMed Hymes, S. R., Strom, E. A., & Fife, C. (2006). Radiation dermatitis: Clinical presentation, pathophysiology, and treatment 2006. Journal of the American Academy of Dermatology, 54(1), 28–46.CrossRefPubMed
4.
Zurück zum Zitat Chan, R. J., Webster, J., Chung, B., Marquart, L., Ahmed, M., & Garantziotis, S. (2014). Prevention and treatment of acute radiation-induced skin reactions: A systematic review and meta-analysis of randomized controlled trials. BMC Cancer, 14, 53.CrossRefPubMedPubMedCentral Chan, R. J., Webster, J., Chung, B., Marquart, L., Ahmed, M., & Garantziotis, S. (2014). Prevention and treatment of acute radiation-induced skin reactions: A systematic review and meta-analysis of randomized controlled trials. BMC Cancer, 14, 53.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Neben-Wittich, M. A., Atherton, P. J., Schwartz, D. J., Sloan, J. A., Griffin, P. C., Deming, R. L., Anders, J. C., Loprinzi, C. L., Burger, K. N., Martenson, J. A., & Miller, R. C. (2011). Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: The North Central Cancer Treatment Group (N06C4). International Journal of Radiation Oncology, Biology, Physics, 81(2), 397–402.CrossRefPubMed Neben-Wittich, M. A., Atherton, P. J., Schwartz, D. J., Sloan, J. A., Griffin, P. C., Deming, R. L., Anders, J. C., Loprinzi, C. L., Burger, K. N., Martenson, J. A., & Miller, R. C. (2011). Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: The North Central Cancer Treatment Group (N06C4). International Journal of Radiation Oncology, Biology, Physics, 81(2), 397–402.CrossRefPubMed
6.
Zurück zum Zitat Basch, E., Iasonos, A., McDonough, T., Barz, A., Culkin, A., Kris, M. G., Scher, H. I., & Schrag, D. (2006). Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. The Lancet Oncology, 7(11), 903–909.CrossRefPubMed Basch, E., Iasonos, A., McDonough, T., Barz, A., Culkin, A., Kris, M. G., Scher, H. I., & Schrag, D. (2006). Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. The Lancet Oncology, 7(11), 903–909.CrossRefPubMed
7.
Zurück zum Zitat Chen, A. P., Setser, A., Anadkat, M. J., Cotliar, J., Olsen, E. A., Garden, B. C., & Lacouture, M. E. (2012). Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0. Journal of the American Academy of Dermatology, 67(5), 1025–1039.CrossRefPubMed Chen, A. P., Setser, A., Anadkat, M. J., Cotliar, J., Olsen, E. A., Garden, B. C., & Lacouture, M. E. (2012). Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0. Journal of the American Academy of Dermatology, 67(5), 1025–1039.CrossRefPubMed
8.
Zurück zum Zitat Harsolia, A., Kestin, L., Grills, I., Wallace, M., Jolly, S., Jones, C., Lala, M., Martinez, A., Schell, S., & Vicini, F. A. (2007). Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 68(5), 1375–1380.CrossRefPubMed Harsolia, A., Kestin, L., Grills, I., Wallace, M., Jolly, S., Jones, C., Lala, M., Martinez, A., Schell, S., & Vicini, F. A. (2007). Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 68(5), 1375–1380.CrossRefPubMed
9.
Zurück zum Zitat Kang, H. C., Ahn, S. D., Choi, D. H., Kang, M. K., Chung, W. K., & Wu, H. G. (2014). The safety and efficacy of EGF-based cream for the prevention of radiotherapy-induced skin injury: results from a multicenter observational study. Radiation Oncology Journal, 32(3), 156–162.CrossRefPubMedPubMedCentral Kang, H. C., Ahn, S. D., Choi, D. H., Kang, M. K., Chung, W. K., & Wu, H. G. (2014). The safety and efficacy of EGF-based cream for the prevention of radiotherapy-induced skin injury: results from a multicenter observational study. Radiation Oncology Journal, 32(3), 156–162.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Faithfull, S., Lemanska, A., & Chen, T. (2015). Patient-reported outcome measures in radiotherapy: Clinical advances and research opportunities in measurement for survivorship. Clinical Oncology, 27(11), 679–685.CrossRefPubMed Faithfull, S., Lemanska, A., & Chen, T. (2015). Patient-reported outcome measures in radiotherapy: Clinical advances and research opportunities in measurement for survivorship. Clinical Oncology, 27(11), 679–685.CrossRefPubMed
11.
Zurück zum Zitat FDA. (2006). Draft guidance for industry on patient-reported outcome measures: Use in medicinal product development to support labeling claims. Fed Register, 71, 5862–5863. FDA. (2006). Draft guidance for industry on patient-reported outcome measures: Use in medicinal product development to support labeling claims. Fed Register, 71, 5862–5863.
12.
Zurück zum Zitat Kluetz, P. G., Chingos, D. T., Basch, E. M., & Mitchell, S. A. (2016). Patient-reported outcomes in cancer clinical trials: Measuring symptomatic adverse events with the national cancer institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). American Society of Clinical Oncology Educational Book, 35, 67–73.CrossRefPubMed Kluetz, P. G., Chingos, D. T., Basch, E. M., & Mitchell, S. A. (2016). Patient-reported outcomes in cancer clinical trials: Measuring symptomatic adverse events with the national cancer institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). American Society of Clinical Oncology Educational Book, 35, 67–73.CrossRefPubMed
13.
Zurück zum Zitat Vacek, P. M., Winstead-Fry, P., Secker-Walker, R. H., Hooper, G. J., & Plante, D. A. (2003). Factors influencing quality of life in breast cancer survivors. Quality of Life Research, 12(5), 527–537.CrossRefPubMed Vacek, P. M., Winstead-Fry, P., Secker-Walker, R. H., Hooper, G. J., & Plante, D. A. (2003). Factors influencing quality of life in breast cancer survivors. Quality of Life Research, 12(5), 527–537.CrossRefPubMed
14.
Zurück zum Zitat Harris, R., Probst, H., Beardmore, C., James, S., Dumbleton, C., Bolderston, A., Faithfull, S., Wells, M., & Southgate, E. (2012). Radiotherapy skin care: A survey of practice in the UK. Radiography, 18(1), 21–27.CrossRef Harris, R., Probst, H., Beardmore, C., James, S., Dumbleton, C., Bolderston, A., Faithfull, S., Wells, M., & Southgate, E. (2012). Radiotherapy skin care: A survey of practice in the UK. Radiography, 18(1), 21–27.CrossRef
15.
Zurück zum Zitat O’Donovan, A., Coleman, M., Harris, R., & Herst, P. (2015). Prophylaxis and management of acute radiation-induced skin toxicity: a survey of practice across Europe and the USA. European Journal of Cancer Care, 24(3), 425–435.CrossRefPubMed O’Donovan, A., Coleman, M., Harris, R., & Herst, P. (2015). Prophylaxis and management of acute radiation-induced skin toxicity: a survey of practice across Europe and the USA. European Journal of Cancer Care, 24(3), 425–435.CrossRefPubMed
16.
Zurück zum Zitat Bolderston, A., Lloyd, N. S., Wong, R. K., Holden, L., Robb-Blenderman, L., & Supportive Care Guidelines Group of Cancer Care Ontario Program in Evidence-Based, C. (2006). The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline. Support Care Cancer, 14(8), 802–817.CrossRefPubMed Bolderston, A., Lloyd, N. S., Wong, R. K., Holden, L., Robb-Blenderman, L., & Supportive Care Guidelines Group of Cancer Care Ontario Program in Evidence-Based, C. (2006). The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline. Support Care Cancer, 14(8), 802–817.CrossRefPubMed
17.
Zurück zum Zitat Atherton, P. J., Burger, K. N., Loprinzi, C. L., Neben Wittich, M. A., Miller, R. C., Jatoi, A., & Sloan, J. A. (2012). Using the Skindex-16 and common terminology criteria for adverse events to assess rash symptoms: Results of a pooled-analysis (N0993). Supportive Care in Cancer, 20(8), 1729–1735.CrossRefPubMed Atherton, P. J., Burger, K. N., Loprinzi, C. L., Neben Wittich, M. A., Miller, R. C., Jatoi, A., & Sloan, J. A. (2012). Using the Skindex-16 and common terminology criteria for adverse events to assess rash symptoms: Results of a pooled-analysis (N0993). Supportive Care in Cancer, 20(8), 1729–1735.CrossRefPubMed
18.
Zurück zum Zitat Huang, C. J., Hou, M. F., Luo, K. H., Wei, S. Y., Huang, M. Y., Su, S. J., Kuo, H. Y., Yuan, S. S., Chen, G. S., Chu-Sung Hu, S., & Chuang, H. Y. (2015). RTOG, CTCAE and WHO criteria for acute radiation dermatitis correlate with cutaneous blood flow measurements. Breast, 24(3), 230–236.CrossRefPubMed Huang, C. J., Hou, M. F., Luo, K. H., Wei, S. Y., Huang, M. Y., Su, S. J., Kuo, H. Y., Yuan, S. S., Chen, G. S., Chu-Sung Hu, S., & Chuang, H. Y. (2015). RTOG, CTCAE and WHO criteria for acute radiation dermatitis correlate with cutaneous blood flow measurements. Breast, 24(3), 230–236.CrossRefPubMed
19.
Zurück zum Zitat Bottomley, A., Jones, D., & Claassens, L. (2009). Patient-reported outcomes: Assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. European Journal of Cancer, 45(3), 347–353.CrossRefPubMed Bottomley, A., Jones, D., & Claassens, L. (2009). Patient-reported outcomes: Assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. European Journal of Cancer, 45(3), 347–353.CrossRefPubMed
20.
Zurück zum Zitat Kumar, S., Juresic, E., Barton, M., & Shafiq, J. (2010). Management of skin toxicity during radiation therapy: A review of the evidence. Journal of Medical Imaging and Radiation Oncology, 54(3), 264–279.CrossRefPubMed Kumar, S., Juresic, E., Barton, M., & Shafiq, J. (2010). Management of skin toxicity during radiation therapy: A review of the evidence. Journal of Medical Imaging and Radiation Oncology, 54(3), 264–279.CrossRefPubMed
21.
Zurück zum Zitat Rutqvist, L. E., Rose, C., & Cavallin-ståhl, E. (2003). A systematic overview of radiation therapy effects in breast cancer. Acta Oncologica, 42(5–6), 532–545.CrossRefPubMed Rutqvist, L. E., Rose, C., & Cavallin-ståhl, E. (2003). A systematic overview of radiation therapy effects in breast cancer. Acta Oncologica, 42(5–6), 532–545.CrossRefPubMed
22.
Zurück zum Zitat Szumacher, E., Wighton, A., Franssen, E., Chow, E., Tsao, M., Ackerman, I., Andersson, L., Kim, J., Wojcicka, A., Ung, Y., Sixel, K., & Hayter, C. (2001). Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy. International Journal of Radiation Oncology, Biology, Physics, 51(1), 81–86.CrossRefPubMed Szumacher, E., Wighton, A., Franssen, E., Chow, E., Tsao, M., Ackerman, I., Andersson, L., Kim, J., Wojcicka, A., Ung, Y., Sixel, K., & Hayter, C. (2001). Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy. International Journal of Radiation Oncology, Biology, Physics, 51(1), 81–86.CrossRefPubMed
23.
Zurück zum Zitat McGale, P., Taylor, C., Correa, C., Cutter, D., Duane, F., Ewertz, M., Gray, R., Mannu, G., Peto, R., Whelan, T., Wang, Y., Wang, Z., & Darby, S. (2014). Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet, 383(9935), 2127–2135.CrossRefPubMed McGale, P., Taylor, C., Correa, C., Cutter, D., Duane, F., Ewertz, M., Gray, R., Mannu, G., Peto, R., Whelan, T., Wang, Y., Wang, Z., & Darby, S. (2014). Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet, 383(9935), 2127–2135.CrossRefPubMed
24.
Zurück zum Zitat Darby, S., McGale, P., Correa, C., Taylor, C., Arriagada, R., Clarke, M., Cutter, D., Davies, C., Ewertz, M., Godwin, J., Gray, R., Pierce, L., Whelan, T., Wang, Y., & Peto, R. (2011). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet, 378(9804), 1707–1716.CrossRefPubMed Darby, S., McGale, P., Correa, C., Taylor, C., Arriagada, R., Clarke, M., Cutter, D., Davies, C., Ewertz, M., Godwin, J., Gray, R., Pierce, L., Whelan, T., Wang, Y., & Peto, R. (2011). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet, 378(9804), 1707–1716.CrossRefPubMed
25.
Zurück zum Zitat Lee, S. Y., Kwon, H. C., Kim, J. S., & Lee, H.-K. (2010). An analysis of the incidence and related factors for radiation dermatitis in breast cancer patients who received radiation therapy. The Journal of the Korean Society for Therapeutic Radiology and Oncology, 28(1), 16.CrossRef Lee, S. Y., Kwon, H. C., Kim, J. S., & Lee, H.-K. (2010). An analysis of the incidence and related factors for radiation dermatitis in breast cancer patients who received radiation therapy. The Journal of the Korean Society for Therapeutic Radiology and Oncology, 28(1), 16.CrossRef
26.
Zurück zum Zitat Harper, J. L., Franklin, L. E., Jenrette, J. M., & Aguero, E. G. (2004). Skin toxicity during breast irradiation: pathophysiology and management. Southern Medical Journal, 97(10), 989–993.CrossRefPubMed Harper, J. L., Franklin, L. E., Jenrette, J. M., & Aguero, E. G. (2004). Skin toxicity during breast irradiation: pathophysiology and management. Southern Medical Journal, 97(10), 989–993.CrossRefPubMed
27.
Zurück zum Zitat Vogelzang, N. J., Breitbart, W., Cella, D., Curt, G. A., Groopman, J. E., Horning, S. J., Itri, L. M., Johnson, D. H., Scherr, S. L., & Portenoy, R. K. (1997). Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Seminars in Hematology, 34(3 Suppl 2), 4–12.PubMed Vogelzang, N. J., Breitbart, W., Cella, D., Curt, G. A., Groopman, J. E., Horning, S. J., Itri, L. M., Johnson, D. H., Scherr, S. L., & Portenoy, R. K. (1997). Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Seminars in Hematology, 34(3 Suppl 2), 4–12.PubMed
28.
Zurück zum Zitat Fromme, E. K., Eilers, K. M., Mori, M., Hsieh, Y. C., & Beer, T. M. (2004). How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. Journal of Clinical Oncology 22(17), 3485–3490.CrossRefPubMed Fromme, E. K., Eilers, K. M., Mori, M., Hsieh, Y. C., & Beer, T. M. (2004). How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. Journal of Clinical Oncology 22(17), 3485–3490.CrossRefPubMed
29.
Zurück zum Zitat Patrick, D. L., Ferketich, S. L., Frame, P. S., Harris, J. J., Hendricks, C. B., Levin, B., Link, M. P., Lustig, C., McLaughlin, J., Ried, L. D., Turrisi, A. T. 3rd, Unutzer, J., & Vernon, S. W. (2003). National institutes of health state-of-the-science conference statement: Symptom management in cancer: Pain, depression, and fatigue, July 15–17, 2002. Journal of the National Cancer Institute, 95(15), 1110–1117.CrossRefPubMed Patrick, D. L., Ferketich, S. L., Frame, P. S., Harris, J. J., Hendricks, C. B., Levin, B., Link, M. P., Lustig, C., McLaughlin, J., Ried, L. D., Turrisi, A. T. 3rd, Unutzer, J., & Vernon, S. W. (2003). National institutes of health state-of-the-science conference statement: Symptom management in cancer: Pain, depression, and fatigue, July 15–17, 2002. Journal of the National Cancer Institute, 95(15), 1110–1117.CrossRefPubMed
30.
Zurück zum Zitat Noh, J. M., Choi, D. H., Park, H., Huh, S. J., Park, W., Seol, S. W., Jeong, B. K., Nam, S. J., Lee, J. E., & Kil, W. H. (2014). Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection. Journal of Radiation Research, 55(3), 553–558.CrossRefPubMedPubMedCentral Noh, J. M., Choi, D. H., Park, H., Huh, S. J., Park, W., Seol, S. W., Jeong, B. K., Nam, S. J., Lee, J. E., & Kil, W. H. (2014). Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection. Journal of Radiation Research, 55(3), 553–558.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Montazeri, A. (2008). Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. Journal of Experimental & Clinical Cancer Research: CR, 27, 32.CrossRefPubMedCentral Montazeri, A. (2008). Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. Journal of Experimental & Clinical Cancer Research: CR, 27, 32.CrossRefPubMedCentral
32.
Zurück zum Zitat Ebanks, J. P., Wickett, R. R., & Boissy, R. E. (2009). Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration. The International Journal of Molecular Sciences, 10(9), 4066–4087.CrossRefPubMed Ebanks, J. P., Wickett, R. R., & Boissy, R. E. (2009). Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration. The International Journal of Molecular Sciences, 10(9), 4066–4087.CrossRefPubMed
33.
Zurück zum Zitat McQuestion, M. (2006). Evidence-based skin care management in radiation therapy. Seminars in Oncology Nursing, 22(3), 163–173.CrossRefPubMed McQuestion, M. (2006). Evidence-based skin care management in radiation therapy. Seminars in Oncology Nursing, 22(3), 163–173.CrossRefPubMed
34.
Zurück zum Zitat Lee, J. H., Kay, C. S., Maeng, L. S., Oh, S. J., Lee, A. H., Lee, J. D., Han, C. W., & Cho, S. H. (2009). The clinical features and pathophysiology of acute radiation dermatitis in patients receiving tomotherapy. Annals of Dermatology, 21(4), 358–363.CrossRefPubMedPubMedCentral Lee, J. H., Kay, C. S., Maeng, L. S., Oh, S. J., Lee, A. H., Lee, J. D., Han, C. W., & Cho, S. H. (2009). The clinical features and pathophysiology of acute radiation dermatitis in patients receiving tomotherapy. Annals of Dermatology, 21(4), 358–363.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Hu, S. C., Hou, M. F., Luo, K. H., Chuang, H. Y., Wei, S. Y., Chen, G. S., Chiang, W., & Huang, C. J. (2014). Changes in biophysical properties of the skin following radiotherapy for breast cancer. The Journal of Dermatology, 41(12), 1087–1094.CrossRefPubMed Hu, S. C., Hou, M. F., Luo, K. H., Chuang, H. Y., Wei, S. Y., Chen, G. S., Chiang, W., & Huang, C. J. (2014). Changes in biophysical properties of the skin following radiotherapy for breast cancer. The Journal of Dermatology, 41(12), 1087–1094.CrossRefPubMed
36.
Zurück zum Zitat Salvo, N., Barnes, E., van Draanen, J., Stacey, E., Mitera, G., Breen, D., Giotis, A., Czarnota, G., Pang, J., & De Angelis, C. (2010). Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature. Current Oncology, 17(4), 94–112.PubMedPubMedCentral Salvo, N., Barnes, E., van Draanen, J., Stacey, E., Mitera, G., Breen, D., Giotis, A., Czarnota, G., Pang, J., & De Angelis, C. (2010). Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature. Current Oncology, 17(4), 94–112.PubMedPubMedCentral
37.
Zurück zum Zitat Richardson, J., Smith, J. E., McIntyre, M., Thomas, R., & Pilkington, K. (2005). Aloe Vera for preventing radiation-induced skin reactions: A systematic literature review. Clinical Oncology, 17(6), 478–484.CrossRefPubMed Richardson, J., Smith, J. E., McIntyre, M., Thomas, R., & Pilkington, K. (2005). Aloe Vera for preventing radiation-induced skin reactions: A systematic literature review. Clinical Oncology, 17(6), 478–484.CrossRefPubMed
Metadaten
Titel
Patient-reported symptoms of radiation dermatitis during breast cancer radiotherapy: a pilot study
verfasst von
Jieun Lee
Won Park
Doo Ho Choi
Seung Jae Huh
Im-Ryung Kim
Danbee Kang
Juhee Cho
Publikationsdatum
25.02.2017
Verlag
Springer International Publishing
Erschienen in
Quality of Life Research / Ausgabe 7/2017
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-017-1526-4

Weitere Artikel der Ausgabe 7/2017

Quality of Life Research 7/2017 Zur Ausgabe